Pharmacologic inhibition of CamKIV by the inhibitor KN93 or genetic inhibition of CamKIV decreases frequency of IL-17 producing cells and efficiently decreases lupus-like disease in murine models and ameliorates experimental autoimmune encephalomyelitis (47, 48). The gene discussed is IL17A; the disease is experimental autoimmune encephalomyelitis.